Lam Research Corporation

NASDAQ:LRCX

Semiconductors

Technology
$211.67 +5.26%

+$19.70 today

Market cap
$264.41B
Beta
1.87
P/E (TTM)
73.4
EPS (TTM)
$5.37
Dividend yield
0.26%
52W Low $87.75High $401.00

Volume 7.61M

Average 11.84M

LRCX Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Lam Research CorporationNASDAQ: LRCX

Research & Development · Q1 FY2027 · quarter ended Sep 2026

Research & development growth accelerates

Q1 FY2027 research & development of $666.4M rose 15.6% year over year, ahead of the +13.2% change in trailing-twelve-month research & development. Sequentially, it rose 3.7% from the prior quarter. Over 3 fiscal years it compounded at +11.2% a year.

Context

  • Research & development amounted to 10.2% of revenue in FY2026, down 1.1 pp from a year earlier.
  • Research & development increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +15.6% holds above the trailing-twelve-month pace of +13.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$666.4M+3.7% QoQ
Last fiscal yearJun 2026
$2.38B+13.3% YoY
LTMSep 2026
$2.47B+13.2% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+15.6%——
1 year+13.3%——
3-year CAGR+11.2%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2026
2.38B USD
Year-over-year change
+13.3%
4-year CAGR
+10.3%

Research & Development vs competitors

How LRCX compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +13.2% is the 3rd highest of 6, against a peer median of +12.6%.
  • Research & development amounts to 9.4% of revenue for LRCX, versus a peer median of 12.4%.
LRCX Competitors
Research & Development for LRCX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ASMLASML Holding N.V.LTM Sep 2026€4.9B EUR+7.6%+15.2%12.4%
AMATApplied Materials, Inc.LTM Oct 2026$4.18B USD+17.2%+10.5%12.1%
LRCXLam Research CorporationLTM Sep 2026$2.47B USD+13.2%+11.2%9.4%
KLACKLA CorporationLTM Jun 2026$1.53B USD+12.6%+5.7%11.3%
ACMRACM Research, Inc.LTM Sep 2026$174.19M USD+35.3%+32.6%15.3%
VECOVeeco Instruments Inc.LTM Sep 2026$128.86M USD+7.4%+4.9%17.7%
Peer median (excluding LRCX) —+12.6%+10.5%12.4%

Competitors are the stored peer set for LRCX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Revenue17.23B17.43B14.91B18.44B23.23B
Cost of Revenue9.36B9.65B7.85B9.46B11.51B
Gross Profit7.87B7.78B7.05B8.98B11.73B
Gross Margin45.7%44.6%47.3%48.7%50.5%
Research & Development1.6B1.73B1.9B2.1B2.38B
Selling, General & Admin885.74M832.75M868.25M981.7M1.15B
Operating Expenses2.49B2.6B2.79B3.08B3.53B
Depreciation & Amortization333.74M342.43M359.7M386.28M441.53M
EBITDA5.71B5.64B4.91B6.34B8.7B
EBITDA Margin33.2%32.4%32.9%34.4%37.5%
Operating Income5.38B5.17B4.26B5.9B8.2B
Operating Margin31.2%29.7%28.6%32.0%35.3%
Interest Income15.21M138.98M251.94M231.33M0
Interest Expense184.76M186.46M185.24M178.2M0
Other Income / Expenses(188.71M)(65.65M)96.31M57.16M62.68M
Income Before Tax5.19B5.11B4.36B5.96B8.26B
Pre-Tax Margin30.1%29.3%29.3%32.3%35.6%
Income Tax Expense587.83M598.28M532.45M599.91M997.08M
Net Income4.61B4.51B3.83B5.36B7.27B
Net Margin26.7%25.9%25.7%29.1%31.3%
EPS (Basic)3.293.332.914.175.79
EPS (Diluted)3.273.322.904.155.76
Weighted Avg Shares1.4B1.35B1.31B1.29B1.26B
Weighted Avg Shares (Diluted)1.41B1.36B1.32B1.29B1.26B

Lam Research Corporation

NASDAQ:LRCX

Intrinsic Alpha fair value

Locked

Current Price

$211.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.